Skip to content

Clinical trials

Phase 2/3 Lung Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2/3 Country / region: United Kingdom Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20051
20112
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
BioNTech SE1
Cancer Research UK1
European Organisation for Research and Treatment of Cancer - EORTC1
Medical Research Council1
NCIC Clinical Trials Group1
Sanofi1
Synta Pharmaceuticals Corp.1
The Christie NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms10
Carcinoma, Non-Small-Cell Lung7
Adenocarcinoma of Lung1
Adenocarcinoma, Bronchiolo-Alveolar1
Colorectal Neoplasms1
Gallbladder Neoplasms1
Hematologic Neoplasms1
Neoplasm Metastasis1
Neoplasms1
Ovarian Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.